Gene · 4598
Papers1,777
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,777
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of human mevalonate kinase by allosteric inhibitors of farnesyl pyrophosphate synthase. | FEBS Open Bio | 2024 | 38923323 | PubTator, text mining | PubMed |
| Gypenoside L inhibits hepatocellular carcinoma by targeting the SREBP2-HMGCS1 axis and enhancing immune response. | Bioorg Chem | 2024 | 38861912 | PubTator, text mining | PubMed |
| Enhancement of production of glycoalkaloids by elicitors along with characterization of gene expression of pathways in Solanum xanthocarpum. | J Biotechnol | 2024 | 38825191 | PubTator, text mining | PubMed |
| Engineering Co3O4@3DOM LaCoO3 multistage-pore nanoreactor with superior SO2 resistance for toluene catalytic combustion. | Nanoscale | 2024 | 38757969 | PubTator, text mining | PubMed |
| A case report of Hyper-IgD syndrome in a 5-year-old girl with recurrent fever, skin rash, and arthralgia; novel MVK mutation (C.298G>A). | Clin Case Rep | 2024 | 38689683 | PubTator, text mining | PubMed |
| Gene-specific somatic epigenetic mosaicism of FDFT1 underlies a non-hereditary localized form of porokeratosis. | Am J Hum Genet | 2024 | 38653249 | PubTator, text mining | PubMed |
| Genomic testing identifies monogenic causes in patients with very early-onset inflammatory bowel disease: a multicenter survey in an Iranian cohort. | Clin Exp Immunol | 2024 | 38651248 | PubTator, text mining | PubMed |
| Multiplex proteomics identifies inflammation-related plasma biomarkers for aging and cardio-metabolic disorders. | Clin Proteomics | 2024 | 38649851 | PubTator, text mining | PubMed |
| Molecular and cellular consequences of mevalonate kinase deficiency. | Biochim Biophys Acta Mol Basis Dis | 2024 | 38636615 | PubTator, text mining | PubMed |
| Mevalonate kinase-deficient THP-1 cells show a disease-characteristic pro-inflammatory phenotype. | Front Immunol | 2024 | 38550596 | PubTator, text mining | PubMed |
| A Water-Promoted Mars-van Krevelen Reaction Dominates Low-Temperature CO Oxidation over Au-Fe2O3 but Not over Au-TiO2. | ACS Catal | 2024 | 38449533 | PubTator, text mining | PubMed |
| Atomically synergistic Zn-Cr catalyst for iso-stoichiometric co-conversion of ethane and CO2 to ethylene and CO. | Nat Commun | 2024 | 38291043 | PubTator, text mining | PubMed |
| Two Novel and Three Recurrent Mutations in the Mevalonate Pathway Genes in Chinese Patients with Porokeratosis. | Clin Cosmet Investig Dermatol | 2024 | 38283795 | PubTator, text mining | PubMed |
| Anakinra in idiopathic recurrent pericarditis: a comprehensive case series and literature review. | Z Rheumatol | 2024 | 38277021 | PubTator, text mining | PubMed |
| Human Nutrition Research in the Data Era: Results of 11 Reports on the Effects of a Multiple-Micronutrient-Intervention Study. | Nutrients | 2024 | 38257081 | PubTator, text mining | PubMed |
| Cytotoxic Effects of Major and Emerging Mycotoxins on HepaRG Cells and Transcriptomic Response after Exposure of Spheroids to Enniatins B and B1. | Toxins (Basel) | 2024 | 38251270 | PubTator, text mining | PubMed |
| First-in-human validation of enzymolysis clearance strategy for decreasing renal radioactivity using modified [68Ga]Ga-HER2 Affibody. | Eur J Nucl Med Mol Imaging | 2024 | 38216779 | PubTator, text mining | PubMed |
| Cholesterol biosynthetic pathway induces cellular senescence through ERRα. | NPJ Aging | 2024 | 38216569 | PubTator, text mining | PubMed |
| Prognostic implication of a novel lactate score correlating with immunotherapeutic responses in pan-cancer. | Aging (Albany NY) | 2024 | 38198170 | PubTator, text mining | PubMed |
| Tocilizumab for treating mevalonate kinase deficiency and TNF receptor-associated periodic syndrome: a case series and literature review. | Pediatr Rheumatol Online J | 2024 | 38183017 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4598/papers?page=5